Page last updated: 2024-12-06
asparkam
Description
Asparkam is a potassium chloride supplement used to treat low potassium levels in the body. It is often prescribed for people with conditions that cause potassium loss, such as diuretic use, severe vomiting, or diarrhea. Asparkam is not synthesized, but rather is a naturally occurring compound. Potassium is an essential mineral that plays a role in many important bodily functions, including nerve impulses, muscle contractions, and heart rhythm. When potassium levels are low, it can lead to a variety of symptoms such as muscle weakness, fatigue, and irregular heartbeat. Asparkam is studied to understand its efficacy in treating low potassium levels and to determine the optimal dosage and route of administration. It is considered safe and effective when used as directed. However, it can interact with certain medications, and it is important to consult with a healthcare provider before taking Asparkam.'
Asparkam: Asparkam tablets contain potassium & magnesium aspartate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 71375 |
MeSH ID | M0083102 |
Synonyms (13)
Synonym |
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-kappan,kappao1)magnesate(2-) |
potassium aspartate and magnesium aspartate [usan:jan] |
wy 2837 |
potassium aspartate and magnesium aspartate |
magnesium potassium l-aspartate |
asparkam |
wy 2838 |
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-n,o(sup 1)magnesate(2-) |
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-n,o1)magnesate(2-) |
14842-81-0 |
unii-55tui7q42i |
magnesate(2-), bis(laspartato(2-)-kappan,kappao1)-, (t-4)-, dihydrogen, mixt. contg. |
magnesium;potassium;(2s)-2-amino-4-hydroxy-4-oxobutanoate;2-amino-4-hydroxy-4-oxobutanoate |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 51.45
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 51.45 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.18 (4.65) | Search Engine Demand Index | 76.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |